[Ankylosing spondylitis].
Komiya
Setsuro
S
Department of Orthopaedic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001799:Blood Sedimentation; D015519:Bone Density; D003937:Diagnosis, Differential; D000068800:Etanercept; D015796:HLA-B27 Antigen; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D000069285:Infliximab; D007375:Interleukin-1 / Q000235:genetics; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000627:therapeutic use; D019637:Orthopedic Procedures; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D016212:Transforming Growth Factor beta
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015796:HLA-B27 Antigen; D007074:Immunoglobulin G; D007375:Interleukin-1; D018124:Receptors, Tumor Necrosis Factor; D016212:Transforming Growth Factor beta; D000069285:Infliximab; D000068800:Etanercept; D008727:Methotrexate